How can antimicrobial formulations be optimized for cost and efficacy in food systems?

Designing antimicrobial systems that are both effective and economically viable is a core challenge for food R&D teams. Increasing raw material costs, higher shelf-life expectations, and pressure to reduce food waste are driving the need for cost effective antimicrobial formulation strategies.

Recent data illustrates the scale of the issue: approximately 14% of food is lost globally before reaching retail, with microbial spoilage as a major contributing factor (FAO, 2023). In parallel, manufacturers must meet stricter requirements related to labeling, functionality, and product quality.

In this context, cost-effectiveness cannot be reduced to ingredient price. It is more accurately defined as:
the ability of a formulation to deliver the required microbial stability at the lowest total cost per unit of performance, within defined product and processing constraints.

This reframes the challenge from ingredient selection to system-level optimization.

From antimicrobial activity to system performance

Evaluating antimicrobial efficacy requires moving beyond simplified laboratory metrics. While minimum inhibitory concentration (MIC) provides useful screening information, it does not capture the complexity of food systems.

For R&D decision-making, challenge tests and shelf-life studies are critical. These approaches integrate key variables such as matrix composition, microbial ecology, and process conditions.

An important consideration is the non-linear dose–response relationship. Increasing concentration does not result in proportional gains in microbial inhibition, leading to diminishing returns at higher inclusion levels.
For instance, at Galactic Innovation Campus, in our lab, refrigerated beef patties stored at 4°C, the addition of 1.3% of a vinegar-based antimicrobial system significantly slowed aerobic bacterial growth compared to a control, extending microbial stability over a 17-day period while maintaining stable pH and water activity. This illustrates that precise dosing can deliver meaningful shelf-life gains without unnecessary cost escalation.

Understanding cost drivers beyond ingredient price

In practice, the total cost of an antimicrobial system is often misinterpreted. The price per kilogram of an ingredient is only one variable. More relevant cost drivers include:

• the effective dosage required in a specific food matrix
• activity losses during processing (heat, pH shifts, interactions with proteins or lipids)
• the distribution and localization of the antimicrobial within the product
• the reduction of risks such as spoilage, rework, or product withdrawal
• the economic value of shelf-life extension

A lower-cost ingredient that requires higher usage levels or performs inconsistently may increase total formulation cost. Conversely, a system that achieves microbial control at lower inclusion levels can significantly improve cost efficiency.

Formulation strategies to improve efficiency per unit

Optimizing dose–response behavior

Identifying the minimum effective concentration under realistic conditions is a primary lever. This requires generating full dose–response curves rather than relying on standard inclusion rates, avoiding both under- and over-formulation.

Leveraging synergy and hurdle design

Combining antimicrobial mechanisms is one of the most effective strategies for improving efficiency.
Synergies can arise between:

• organic acids and their salts
• pH control and antimicrobial activity
• antimicrobial systems and packaging conditions such as vacuum

These interactions allow a reduction in the required level of each component while maintaining overall efficacy, improving the cost-to-performance ratio.

Managing the product environment

The activity of many antimicrobials is strongly influenced by pH and water activity. Adjusting these parameters can significantly enhance performance without increasing ingredient usage.
In the example above, the stability of pH throughout storage supported consistent antimicrobial activity, in contrast to the control where microbial metabolism altered the environment.

Targeting contamination pathways

Microbial contamination often occurs on the surface. In such cases, targeted application strategies (for example, surface treatments or marinades) can be more efficient than homogeneous incorporation, reducing overall usage levels.

Natural versus traditional antimicrobials: formulation perspective

Both conventional and naturally derived antimicrobials are relevant tools for food manufacturers. Their differences are best understood in terms of formulation approach rather than perceived performance.
Conventional antimicrobials are typically single, well-defined molecules with predictable dose–response behavior, which can simplify formulation.

Naturally derived antimicrobial systems, such as vinegar-based or fermentation-derived solutions, function as multicomponent systems. Their performance depends on the interaction of several active compounds and their integration into the food matrix.

As a result, they benefit from a more integrated formulation approach, where parameters such as pH, matrix composition, and process conditions are considered collectively.

This should not be interpreted as a limitation. On the contrary, this complexity enables:

• multiple modes of antimicrobial action
• inherent synergy between components
• the potential to combine functional effects, such as acidification and microbial inhibition

When properly optimized, these systems can deliver high efficiency per unit used, as illustrated by the performance observed at 1.3% in the beef application. A cost-effective antimicrobial formulation is not defined by ingredient cost alone, but by how efficiently it delivers microbial stability within a given system.

Key principles include:

• evaluating performance under realistic conditions
• accounting for non-linear dose–response relationships
• leveraging synergy and product environment
• adopting a system-level formulation mindset

The example of a vinegar-based antimicrobial, that we used above, at 1.3% demonstrates that precision in formulation enables strong microbial control without excessive cost input.

For R&D teams, the challenge is not to identify the lowest-cost antimicrobial, but to design systems that achieve the lowest cost per unit of microbial stability, combining scientific understanding with practical formulation expertise. With Galactic, you access hands-on formulation expertise to translate antimicrobial performance data into cost-efficient, application-ready solutions.